Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 459

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 459
---
 ​ 
           ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | 2022 
 ​    
 ​    | ​ 
 ​ |           ​ 
           ​ | ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|:--|:-------------|:--|------------:|:--|:--|:--|:-----|:--|------------:|:--|:--|
| Cash(1)                                                                                                                                                                                                                                             | ​ | ​ | ​            | $ |     156,425 | ​ | ​ | ​ | ​    | $ |     280,640 | ​ | ​ |
| Due from Sponsor                                                                                                                                                                                                                                    | ​ | ​ | ​            | ​ |       1,256 | ​ | ​ | ​ | ​    | ​ |       1,256 | ​ | ​ |
| Franchise tax receivable                                                                                                                                                                                                                            | ​ | ​ | ​            | ​ |      53,200 | ​ | ​ | ​ | ​    | ​ |           — | ​ | ​ |
| Prepaid expenses and other current assets                                                                                                                                                                                                           | ​ | ​ | ​            | ​ |           — | ​ | ​ | ​ | ​    | ​ |      78,753 | ​ | ​ |
| Total current assets                                                                                                                                                                                                                                | ​ | ​ | ​            | ​ |     210,881 | ​ | ​ | ​ | ​    | ​ |     360,649 | ​ | ​ |
| Cash and cash equivalents held in Trust Account                                                                                                                                                                                                     | ​ | ​ | ​            | ​ |   4,291,332 | ​ | ​ | ​ | ​    | ​ |  15,127,621 | ​ | ​ |
| Total Assets                                                                                                                                                                                                                                        | ​ | ​ | ​            | $ |   4,502,213 | ​ | ​ | ​ | ​    | $ |  15,488,270 | ​ | ​ |
| Liabilities, Common Stock Subject to Possible Redemption and Stockholders’Deficit                                                                                                                                                                   | ​ | ​ | ​            | ​ |           ​ | ​ | ​ | ​ | ​    | ​ |           ​ | ​ | ​ |
| Current liabilities                                                                                                                                                                                                                                 | ​ | ​ | ​            | ​ |           ​ | ​ | ​ | ​ | ​    | ​ |           ​ | ​ | ​ |
| Accounts payable and accrued expenses                                                                                                                                                                                                               | ​